.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Long-term registry data comparing endothelial and full-thickness corneal transplantation provide useful context for surgical decision-making. In a Singapore Corneal Transplant Registry cohort, eyes undergoing DMEK, DSAEK, and penetrating keratoplasty (PK) for Fuchs endothelial corneal dystrophy or bullous keratopathy were followed for graft survival. DMEK showed the highest cumulative graft survival in the reported cohort, followed by DSAEK and PK. These results support the continued move toward lamellar endothelial replacement when disease is confined to the posterior cornea. However, retrospective registry comparisons can be influenced by patient selection, disease severity, surgeon preference, and changes in surgical practice over time. For clinicians, the key takeaway is that procedure choice should be anatomically driven. DMEK offers selective replacement of dysfunctional endothelium with a small graft, while DSAEK and PK remain valuable when anatomy, visualization, previous surgery, scarring, or other factors make DMEK less suitable. The study is a useful reminder that graft survival is only one outcome; visual rehabilitation, detachment rates, rebubbling, endothelial cell loss, rejection, and technical feasibility should all be integrated into the surgical plan.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Long-term registry data comparing endothelial and full-thickness corneal transplantation provide useful context for surgical decision-making. In a Singapore Corneal Transplant Registry cohort, eyes undergoing DMEK, DSAEK, and penetrating keratoplasty (PK) for Fuchs endothelial corneal dystrophy or bullous keratopathy were followed for graft survival. DMEK showed the highest cumulative graft survival in the reported cohort, followed by DSAEK and PK. These results support the continued move toward lamellar endothelial replacement when disease is confined to the posterior cornea. However, retrospective registry comparisons can be influenced by patient selection, disease severity, surgeon preference, and changes in surgical practice over time. For clinicians, the key takeaway is that procedure choice should be anatomically driven. DMEK offers selective replacement of dysfunctional endothelium with a small graft, while DSAEK and PK remain valuable when anatomy, visualization, previous surgery, scarring, or other factors make DMEK less suitable. The study is a useful reminder that graft survival is only one outcome; visual rehabilitation, detachment rates, rebubbling, endothelial cell loss, rejection, and technical feasibility should all be integrated into the surgical plan.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
